Skip to main content

Table 3 Data concerning infections in the patients studied during the five year study period

From: Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

Most frequently reported infections in 5 years study population (n = 70 patients)

N (%)

Upper respiratory tract infections (rhinosinusitis, pharyngitis, laryngitis, colds)

13 (18.6 %)

Bronchitis/bronchopneumonia

6 (8.6 %)

Conjunctivitis eye disorders

5 (7.1 %)

Influenza episodes

4 (5.7 %)

Diarrhea

4 (5.7 %)

Urinary infections

4 (5.7 %)

Otitis

2 (2.8 %)

Severe skin infections

2 (2.8 %)

Dental infections

2 (2.8 %)

Vaginitis

1 (1.4 %)

Herpes labialis

1 (1.4 %)

Tubal ascess

1 (1.4 %)